Assembly Biosciences is advancing a new class of oral therapeutics for the treatment of hepatitis B (HBV) infection and novel oral live biotherapeutics for disorders associated with the microbiome.
Copyright West LLC. Minimum 15 minutes delayed.
Sep 5, 2019 at 10:15 AM EDT
Jun 22, 2019
Jun 5, 2019